translational genomics research institute Archives

TGen begins Zebrafish pancreatic cancer studies

cancer

For more than a decade, a glassy striped fish smaller than a door key has proved an important model organism in scientific research. Named for the uniform horizontal stripes on the side of its body, the zebrafish is a tiny creature that packs a punch in terms of biological similarities with the human.Today, scientists at… Read More →

Clinical trials change Arizona’s bioscience, business sectors

research

Last November, Arizona voters resoundingly passed Prop. 303 making it legal in Arizona for companies and physicians to provide terminally ill patients the “right to try” investigational drugs or therapies outside an FDA approved clinical trial.    While it sounded good in the short description provided to voters, in reality, it is unlikely to provide… Read More →

RED Awards 2015: General Contractor of the Year

2015 RED Award logo
by in AZRE Magazine | Blogs | Events

On Feb. 26, AZRE hosted the 10th annual RED Awards reception at the Arizona Grand Resort & Spa in Phoenix to recognize the most notable commercial real estate projects of 2014 and the construction teams involved. RED Award trophies were handed out in 10 project categories, to six brokerage teams and safety, subcontractor, architect, general… Read More →

TGen uses X chromosome to uncover disorders in girls

chromosome

Using a basic genetic difference between men and women, the Translational Genomics Research Institute (TGen) has uncovered a way to track down the source of a neurological disorder in a young girl. TGen’s discovery relies on a simple genetic fact: Men have one X and one Y chromosome, while women have two X chromosomes. This… Read More →

TGen and NAU pandemic flu test patent approved

stk99406cor

The federal government has awarded a patent to the Translational Genomics Research Institute (TGen) and Northern Arizona University (NAU) for a test that can detect — and assist in the treatment of — the H1N1 pandemic flu strain. TGen and NAU initially developed this precise, genomics-based test during a significant global swine flu outbreak in… Read More →

TGen, Dell help children with cancer

childrens hospital

Dell, Terascala and the Translational Genomics Research Institute (TGen) are installing state-of-the-art computing and programing specialized for human genome investigations at the National Cancer Institute (NCI). As part of a formal collaboration, Dell is providing the Dell Genomic Data Analysis Platform, designed to deliver fast analysis of the billions of data points required when sequencing,… Read More →

TGen-Ivy Foundation brain cancer trial approved

brain

In 2012, The Ben & Catherine Ivy Foundation awarded $10 million in grants for two groundbreaking brain cancer research projects at the Translational Genomics Research Institute (TGen). One of those projects has officially received the final regulatory approval from University of California, San Francisco, which means patient enrollment for the trial can begin. In the… Read More →

‘Get Your Jersey On’ funds TGen concussion study

brain

Kyrene de las Brisas Elementary School students and teachers will wear their favorite sports team jersey or t-shirt to class today, the first organization to participate in “Get Your Jersey On,” a fun way to help promote and fund concussion research at the Translational Genomics Research Institute (TGen). The Chandler school is the first of… Read More →

ASU, TGen Team Up for Concussion Research

Conquering Concussions

Riddell, the leader in football helmet technology and innovation, and the Translational Genomics Research Institute (TGen), a leader in cutting-edge genomic research, today announced that the Pac-12’s Arizona State University and its Sun Devil football program will again participate in a genetic research study designed to advance athlete concussion detection and treatment. Now in its… Read More →

NIH awards BAI, Mayo $8.3 million

Medical Technology - AZ Business Magazine January/February 2012

The National Institutes of Health (NIH) renewed funding for the Banner Alzheimer’s Institute (BAI) and Mayo Clinic, Phoenix, longitudinal study of the earliest changes associated with the risk of developing Alzheimer’s disease at older ages. The award, an estimated $8.3 million over the next five years, continues NIH’s long-term support of the investigation. The study,… Read More →

TGen study provides new insights on HIV

Hiv+Aids+xgold+2012

A new study led by the Translational Genomics Research Institute (TGen) provides insights into the interplay among bacteria, viruses and the immune system during HIV infection. Currently, doctors measure HIV-positive men’s infectivity — their potential to infect others — based on their blood viral load. However, some men produce large amounts of virus in their… Read More →

TGen study finds origin of lung fungus

Cryptococcus gattii, a virulent fungus that has invaded the Pacific Northwest is highly adaptive and warrants global “public health vigilance,” according to a study by an international team led by the Translational Genomics Research Institute (TGen). C. gattii, which likely originated in Brazil, is responsible for dozens of deaths in recent years since it was… Read More →

TGen teams up with Ceres Nanosciences

bioscience

The Translational Genomics Research Institute (TGen) and Ceres Nanosciences, Inc. (Ceres) today announced a development collaboration to benefit patients with cancer, infectious diseases, and other life-threatening illnesses. TGen, at the heart of Phoenix’s Biomedical Campus, is recognized as a pioneer in studying genomics, or DNA, to uncover the underlying molecular causes of disease, as well… Read More →

TGen, SHC begin clinical trial for anti-tumor drug

The Virginia G. Piper Cancer Center at Scottsdale Healthcare and the Translational Genomics Research Institute (TGen) are studying the safety and effectiveness of a new drug, AG-120, for treatment of patients with solid tumors, especially those with brain tumors and gallbladder bile duct cancer. “AG-120 is designed specifically for those patients who carry the IDH1… Read More →